You can narrow down the results using the filters
-
Australian Trial in Acute Hepatitis C
Expand descriptionA prospective non-randomised dual arm longitudinal cohort of newly acquired hepatitis C infection into which participants will be enrolled and then followed at 3 monthly intervals over a 3 year period. All participants will be offered a 24 week course of Pegylated interferon alfa 2a which will be commenced within 12 weeks of screening.
-
Multi-Center, Phase Ib/IIa Safety and Preliminary Efficacy Study of Phenoxodiol (Intravenous Dosage Form and Oral Dosage Form) as a Chemo-Sensitizing Agent for Cisplatin, Carboplatin and Paclitaxel in Epithelial Ovarian Cancer or Primary Peritoneal Cancer that is Platinum- and/or Taxane-Refractory or Resistant.
Expand description -
A follow-up study of babies with birthweight <2000 gms looking at outcomes and access to appropriate developmental surveillance.
Expand descriptionThis is a study involving children who have all weighed < 2000m and been cared for at the LGH. It aims to evaluate long term outcomes and to look at access to developmental surveillance.
-
COMBINATION ANTI-PARATUBERCULOSIS THERAPY WITH RIFABUTIN, CLARITHROMYCIN AND CLOFAZIMINE FOR CROHNâ¿¿S DISEASE: A THREE YEAR PROSPECTIVE, RANDOMISED, PLACEBO-CONTROLLED, MULTICENTRE STUDY
Expand descriptionAn investigation of the effect of three antibiotics directed against Mycobacterium paratuberculosis, the cause of Johne's disease in sheep and cattle, in patients with active Crohn's disease
-
Radiation Exposure and Safety of Lymphatic Mapping and Selective (Sentinel) Lymph Node Biopsy Procedures for Melanoma and Breast Cancer Treatment
Expand description -
Gastric emptying and malnutrition in adults with cystic fibrosis
Expand description -
Prevalence and predictors of malnutrition and decreased bone density in cystic fibrosis
Expand description -
VMCL Melanoma Vaccine Treatment Phase II Study for Therapy of Patients with Advanced Stage IV Melanoma
Expand description -
Dendritic cell vaccination trial for hormone refractory prostate cancer with autologous tumour as the antigen
Expand description -
Phase I trial of the safety and the effect on immune parameters of an immunotherapy for glioma based on cultured autologous dendritic cells presenting autologous tumour cell antigens derived from irradiated glioma cells
Expand description